C57BL/6JCya-Gpld1em1/Cya
Common Name:
Gpld1-KO
Product ID:
S-KO-02309
Background:
C57BL/6JCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Gpld1-KO
Strain ID
KOCMP-14756-Gpld1-B6J-VA
Gene Name
Product ID
S-KO-02309
Gene Alias
6330541J12Rik
Background
C57BL/6JCya
NCBI ID
Modification
Conventional knockout
Chromosome
13
Phenotype
Document
Application
--
Note: When using this mouse strain in a publication, please cite “C57BL/6JCya-Gpld1em1/Cya mice (Catalog S-KO-02309) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000021773
NCBI RefSeq
NM_008156
Target Region
Exon 3~6
Size of Effective Region
~9.2 kb
Detailed Document
Overview of Gene Research
Gpld1, also known as glycosylphosphatidylinositol-specific phospholipase D1, is an enzyme specific for glycosylphosphatidylinositol (GPI) anchors. It exerts its biological functions by cleaving membrane-associated GPI molecules. GPLD1 is abundant in serum, with a concentration of approximately 5-10 µg/mL. It is involved in numerous biological processes and has been implicated in various chronic diseases, including disorders of lipid and glucose metabolism, cancer, and neurological disorders [1].
Exercise-related studies using Gpld1 -/- mice have shown that Gpld1 is crucial for exercise-induced type I interferon (IFN-I) production in the liver. Exercise-produced 3-hydroxybutanoic acid (3-HB) induces Gpld1 expression in the liver, which then blocks the PP2A-IRF3 interaction, enhancing IRF3 activation and IFN-I production, ultimately improving the body's antiviral ability [2]. In intestinal cancer, ablation of Gpld1+ cells combined with 5-fluorouracil treatment attenuated cell viability and regrowth of cancer organoids. GPLD1 cleaves the GPI anchor of serine protease 8 (PRSS8), activating Wnt signalling and promoting epithelial-mesenchymal transition (EMT) in cancer cells. Pharmacological inhibition of GPLD1 suppressed these processes [3].
In conclusion, Gpld1 plays essential roles in multiple biological processes, especially in the context of exercise-mediated immune responses and cancer development. The use of Gpld1 knockout mouse models has provided valuable insights into its functions in antiviral innate immunity and intestinal cancer, highlighting its potential as a therapeutic target in these disease areas.
References:
1. Cao, Jing, Zhou, Anni, Zhou, Zhuoyang, Liu, Hui, Jia, Shaohui. 2023. The role of GPLD1 in chronic diseases. In Journal of cellular physiology, 238, 1407-1415. doi:10.1002/jcp.31041. https://pubmed.ncbi.nlm.nih.gov/37393554/
2. Ren, Tengfei, He, Jiuyi, Zhang, Tingting, Wu, Depei, Zheng, Hui. 2024. Exercise activates interferon response of the liver via Gpld1 to enhance antiviral innate immunity. In Science advances, 10, eadk5011. doi:10.1126/sciadv.adk5011. https://pubmed.ncbi.nlm.nih.gov/38809975/
3. Mizoo, Taisuke, Oka, Takeru, Sugahara, Osamu, Higa, Tsunaki, Nakayama, Keiichi I. . GPLD1+ cancer stem cells contribute to chemotherapy resistance and tumour relapse in intestinal cancer. In Journal of biochemistry, 177, 105-119. doi:10.1093/jb/mvae082. https://pubmed.ncbi.nlm.nih.gov/39743241/
Quality Control Standard
Sperm Test
Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.
Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.
Environmental Standards:SPF
Available Region:Global
Source:Cyagen